Author/Authors :
Teremmahi Ardestani، Majid نويسنده Department of Immunology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran , , Hadi Nodushan، Hossein نويسنده Department of Immunology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran , , Aflatoonian، Abbas نويسنده , , Ghasemi، Nasrin نويسنده , , Sheikhha، Mohammad Hasan نويسنده ,
Abstract :
Background: Recurrent pregnancy loss (RPL) caused by various genetic and non-genetic factors. After chromosome abnormality, thrombophilia is one of the most important genetic factors that could cause RPL. Factor V Leiden and factor II G20210A mutation were the most common mutations cause thrombophilia in the world. Objective: The purpose of this study was to determine the frequency of factor V Leiden and prothrombine gene mutations in women with RPL compared with women who had uneventful pregnancies. Materials and Methods: This case control study evaluates the frequency of factor V-Leiden and factor II G20210 genotypes in 80 women with two or more pregnancy losses, compared with 80 women without adverse pregnancy outcome. The mutations were assessed by PCR-RFLP. Results: Frequency of the factor V Leiden among cases was 2.5%, which was higher than controls (1.25%), but the difference was not significant. No factor II G20210 mutation was found among cases and controls. Conclusion: These data did not confirm that factor V Leiden and factor II G20210 mutation might play a role in recurrent pregnancy loss in Iranian women